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Background:  Tuberculosis  (TB)  is  the  leading  cause  of  death  in South  Africa.  The  burden  of disease  varies
by  age,  with  peaks  in  TB  notiﬁcation  rates  in the HIV-negative  population  at ages  0−5, 20−24, and  45−49
years.  There  is little  variation  between  age  groups  in the  rates  in the  HIV-positive  population.  The  drivers
of  this  age  pattern  remain  unknown.
Methods:  We  developed  an  age-structured  simulation  model  of  Mycobacterium  tuberculosis  (Mtb)  trans-
mission  in  Cape  Town,  South  Africa.  We  considered  ﬁve  states  of  TB  progression:  susceptible,  infected
(latent  TB),  active  TB, treated  TB, and  treatment  default.  Latently  infected  individuals  could be re-infected;
a previous  Mtb  infection  slowed  progression  to active  disease.  We  further  considered  three  states  of  HIV
progression:  HIV  negative,  HIV  positive,  on  antiretroviral  therapy.  To  parameterize  the  model,  we ana-
lysed  treatment  outcomes  from  the Cape  Town  electronic  TB  register,  social  mixing  patterns  from  a Cape
Town community  and  used  literature  estimates  for  other  parameters.  To  investigate  the  main  drivers
behind  the  age patterns,  we conducted  sensitivity  analyses  on  all parameters  related  to the  age  structure.
Results:  The  model  replicated  the  age  patterns  in  HIV-negative  TB  notiﬁcation  rates  of Cape  Town  in 2009.
Simulated  TB  notiﬁcation  rate  in HIV-negative  patients  was  1000/100,000  person-years  (pyrs)  in  children
aged  <5  years  and  decreased  to 51/100,000  in children  5−15  years.  The  peak in early  adulthood  occurred
at  25−29  years  (463/100,000  pyrs).  After  a subsequent  decline,  simulated  TB notiﬁcation  rates  gradually
increased  from  the age  of 30 years.  Sensitivity  analyses  showed  that  the dip  after  the  early  adult  peak
was  due  to the  protective  effect  of  latent  TB  and  that  retreatment  TB  was  mainly  responsible  for  the rise
in TB  notiﬁcation  rates  from  the  age  of  30 years.
Conclusion:  The  protective  effect  of  a  ﬁrst  latent  infection  on  subsequent  infections  and  the  faster  pro-
gression  in  previously  treated  patients  are  the  key  determinants  of  the  age-structure  of TB  notiﬁcation
rates  in  Cape  Town.
ublis©  2015  The  Authors.  P
. Introduction
The HIV and Tuberculosis (TB) epidemics in South Africa (SA)
re among the worst in the world. Tuberculosis (TB) is now the
eading cause of natural death in South Africa (Statistics South
frica, 2014a). HIV positive individuals who are infected with
ycrobacterium tuberculosis (Mtb) have a substantially higher risk
∗ Corresponding author. Tel.: +41 31 631 35 15.
E-mail address: olivia.keiser@ispm.unibe.ch (O. Keiser).
1 Equally contributing
ttp://dx.doi.org/10.1016/j.epidem.2015.10.001
755-4365/© 2015 The Authors. Published by Elsevier B.V. This is an open access article uhed  by Elsevier  B.V. This  is  an open  access  article  under  the  CC BY  license
(http://creativecommons.org/licenses/by/4.0/).
of developing active TB than their HIV-negative peers (Corbett et al.,
2003), whose lifetime risk following a single infection is about
10% (Styblo, 1991). Even though South Africa has implemented
the World Health Organization (WHO) “Directly observed therapy,
short course” (DOTS, WHO, 1996) strategy, the incidence of TB in
South Africa has continued to rise steadily over the past 20 years,
and reached a rate of 1000 cases per 100,000 person-years in 2012
(WHO, 2013). DOTS has been estimated to reduce TB incidence by
11% per year (Dye et al., 1998), but is failing in HIV endemic sett-
ings (De Cock and Chaisson, 1999). The HIV-associated TB epidemic
partly explains the failure of DOTS to reduce the TB prevalence in SA
(Wood et al., 2011b), since about 65% of TB patients in South Africa
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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ulated individual had characteristics that changed over time: age,
number of previous Mtb  exposures, and number of previous active
TB episodes.
Fig. 1. Model structure. Individuals who start in the susceptible state can be exposed
to  tuberculosis. Exposed individuals can be exposed to a second strain or progressN. Blaser et al. / Epi
re co-infected with HIV (WHO, 2014a). Because Mtb  infection is
reventable and TB disease is curable, effective interventions hold
he potential of drastically lowering infection and mortality rates.
In addition to DOTS, HIV-speciﬁc interventions have been imple-
ented to control TB in this population, including scaling up the use
f antiretroviral therapy (ART) and the “Three I’s” strategy: Inten-
iﬁed case ﬁnding, Isoniazid preventive therapy (IPT) and infection
ontrol (IC) at all clinical encounters (WHO, 2004). Assessing the
mpact of ART on TB incidence is difﬁcult because ART reduces the
isk of TB diseases among HIV-positive individuals and at the same
ime increases the number of people living with HIV due to reduced
IV-related mortality, thereby increasing the population risk of
B (Bacaer et al., 2008; Bhunu et al., 2009). Mathematical models
stimated that universal ART eligibility for all HIV-infected South
fricans would reduce the risk of AIDS-related TB by 48% in 2015
Williams et al., 2010) and reduce new TB cases by 28−37% by 2033
Pretorius et al., 2014). In contrast, Dodd et al. (Dodd et al., 2013)
stimated that TB incidence would initially decline, but rebound
0 years after widespread introduction of ART. Results of mod-
ling studies of IPT are also contradictory. Bacaer et al. (Bacaer
t al., 2008) showed that IPT in HIV-positive individuals could sub-
tantially reduce TB notiﬁcation rates. But Mills et al. (Mills et al.,
011) concluded that the predicted effectiveness of IPT would be
ndermined by repeated re-infections, and Houben et al. (Houben
t al., 2014) found that IPT did not cure latent Mtb  infection in
IV-positive patients.
TB incidence rates are strongly associated with age (Wiker et al.,
010; Wood et al., 2011a). A study of data from the beginning of
he 20th century showed that in the United Kingdom age and rein-
ection after a cured TB episode were important determinants of
ransmission (Vynnycky and Fine, 1997). The authors concluded
hat “the sharp peaks in mortality during young adult life were
ttributable to the combination of a high incidence of (re)infection
nd a rapid risk of developing disease in late adolescence“. The same
ge pattern is also seen today in South Africa: a community-based
tudy in Cape Town, showed that the highest burden of TB had
hifted from the oldest (>60 years) age group to a younger pop-
lation (20−39 year olds) (Lawn et al., 2006). In another study, a
ery distinct age pattern with three notiﬁcation peaks at ages 0−5
ﬁrst peak), 20−24 (second peak), and 45−49 years (third peak)
as observed in the HIV-negative population, whereas in the HIV-
ositive population the burden of TB mirrored age-stratiﬁed HIV
revalence (Wood et al., 2011a). The same study also found a high
urden of TB in patients who were previously treated, with most
atients having no history of treatment failure or default (Wood
t al., 2011a).
Despite being of such importance in TB epidemiology, most
outh African TB models (Aparicio and Castillo-Chavez, 2009;
acaer et al., 2008; Bhunu et al., 2009; Blower et al., 1995; Castillo-
havez and Feng, 1997; Hickson et al., 2012; Mills et al., 2011;
zcaglar et al., 2012; Rodrigues et al., 2007; Roeger et al., 2009;
illiams et al., 2010) do not include age, or include age only for
IV incidence but not for rates of progression from latent Mtb
nfection to active disease or Mtb  transmission. We  chose to model
ape Town because of the high quality of TB notiﬁcation data, and
he high rates of HIV testing. We  aimed to explore the drivers
nderlying the age-patterns in HIV-negative TB notiﬁcation rates
bserved in Cape Town in a mathematical model that includes age-
tratiﬁcation and reinfection.
. Methods.1. Setting
We  modeled the TB dynamics in the city of Cape Town, where
oth TB and HIV are endemic. In 2009, the population of the Capes 14 (2016) 54–61 55
Town metropolitan area was  approximately 3.5 million (Statistics
South Africa, 2014b). HIV prevalence was estimated at around 5%
of the population, and increasing over time (ASSA, 2011). Both HIV
care and TB treatment are provided free of charge in government
clinics across the city. ART was  introduced in 2004 and has been
scaled up since, reaching a coverage of 63% in 2013 (Hermans et al.,
2015a). According to the 2009 National TB management guidelines,
new TB cases are treated for 6 months and TB cases with a history
of previous TB for 9 months (Department of Health, 2009). We  used
these guidelines in our model, because these were the guidelines
that inﬂuenced the current TB incidence and age structure.
2.2. Model structure
We developed an individual-based TB transmission model
stratiﬁed by ﬁve-year age groups. We  used an individual-based
stochastic simulation model because it allowed us to consider
details about individual TB progression depending on age and time
since infection and to capture the uncertainty of modeling outputs.
Individuals were simulated from birth to death using the disease
progression model implemented in the R package gems (Blaser
et al., 2015). We  considered the following stages of TB progression:
susceptible; exposed (latent infection); active disease; treatment;
treatment failure/default; and, recovered/susceptible (Figs. 1 and
S1). Individuals latently infected with Mtb  could be re-infected by
another Mtb  strain or progress to active disease. Active TB cases
were initiated on treatment at a certain rate. After treatment initi-
ation, patients were cured within six months (nine months in the
case of retreatment TB) or they failed treatment. Cured individuals
were considered susceptible to new Mtb  infections (Marx et al.,
2014). In case of reinfection, individuals progressed to active dis-
ease at twice the rate as previously uninfected individuals (Wood
et al., 2011a).
We modeled HIV status of the patients as HIV-negative, HIV-
positive not on ART, and HIV-positive on ART (Figs. 1, S2). We
assumed HIV incidence was  independent of TB progression, but
TB progression depended on HIV status. ART initiation was also
independent of the natural TB progression, but patients treated for
TB were also initiated on ART. We  ﬁrst modeled HIV status over
the entire lifespan and then Mtb  infection and progression based
on HIV status. We  considered heterosexual transmission of HIV
but ignored vertical transmission. We used separate HIV incidence
rates for the pre-ART and ART eras (Table S1). In addition, each sim-to  active TB. Patients with active TB can recover spontaneously or receive treat-
ment. Treated patients either recover and become susceptible again or they default.
Throughout this TB progression, all individuals can also progress in their HIV status,
by  becoming infected and receiving antiretroviral therapy (ART). Even though it is
not represented on the diagram, patients can die at any of the stages.
56 N. Blaser et al. / Epidemics 14 (2016) 54–61
Table 1
Parameter description and values for all model parameters.
Parameter description Depended on Stratiﬁcation Value 95% CI Source
Progression from exposed state
to active TB (rate per year)
Time since
infection
Age ≤ 5 0.24 NA Smith (2001)
5 < age ≤ 10 0.02 NA Ferebee (1970)
10 < age Fig. S4
Rate ratios for progression to
active TB
HIV-positive (vs.
HIV-negative)
6 3.5−8 Corbett et al. (2003)
ART (vs. no ART) 0.50 0.37−0.72 Gupta et al. (2012)
Reinfection with additional
strain (HIV-negative only)
0.21 0.14−0.3 Andrews et al. (2012)
Reinfection after treatment 2 2−3 Wood et al. (2011a) and
Den Boon et al. (2007)
TB treatment rate per year HIV-, smear+ 1.52 NA Wood et al. (2007)
HIV-, smear- 0.15 NA
HIV+, smear+ 0.47 NA
HIV+, smear- 0.23 NA
Spontaneous recovery rate per
year
HIV- 0.25 NA Bacaer et al. (2008) from
Corbett et al. (2003) and
Murray et al. (1990)
TB treatment outcomes Age (in 5-year
groups), HIV
status
First treatment vs.
retreatment
Table S2/S3,
Fig. S6
Data analysis from Cape Town
metropolitan electronic TB
register
Proportion of smear+ age HIV-negative Table S1 Wood et al. (2011a)
HIV-positive
HIV incidence age Time period (pre-HIV, HIV
and ART available)
Table S1 ASSA model (ASSA, 2011)
ART  initiation (for time period
where ART was  available)
No TB treatment 0.13 0.08–0.29 Wandel et al. (2008)
TB treatment 1.27 1.24–1.30 Kaplan et al. (2014)
All-cause mortality rate
(non-HIV, non- TB)
age Table S1 ASSA model (ASSA, 2011)
Mortality rate ratio due to
untreated active TB
17.1 16.8–17.3 Drolet et al. (1952)
Mortality rate ratio for
HIV-related mortality
age Table S1 Sewankambo et al. (2000)
Mortality rate ratio for
mortality on ART
age Table S1 Johnson et al. (2013)
Transmission rate per year 10 6–15 Fit to TB notiﬁcation rates
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.3. Model parameters and data sources
We  used data from the literature and performed dedicated anal-
ses of existing data. HIV incidence rates to parameterize the model,
isease progression rates, treatment outcomes (cure, failure) and
ortality rates were assumed to depend on age. In HIV-negative
hildren below the age of 5 years, and between 5 and 10 years,
e assumed constant TB disease progression rates regardless of
he duration of infection. For older HIV-negative individuals, dis-
ase progression rates depended on the time since Mtb infection:
e ﬁt an exponential decay to the progression rates reported
n Ferebee et al. (Ferebee, 1970) (Fig. S4). Individuals who  were
atently infected and re-infected with another strain of Mtb  had
artial protection and progressed from latent to active TB at a rate
.21 times lower than that of previously uninfected individuals
Andrews et al., 2012). To determine disease progression rates for
IV-positives with and without ART, we applied age-dependent
ate ratios to the parameter estimates from the HIV-negative popu-
ation (Johnson et al., 2013; Sewankambo et al., 2000). Age-speciﬁc
ortality rates were also determined for HIV-negative people with-
ut active TB. We  extracted age-speciﬁc all-cause mortality rates
rom the Actuarial Society of South Africa (ASSA) model for the
estern Cape (ASSA, 2011). Then we used rate ratios to calculate
ortality rates by HIV status and TB status. We  extracted age-peciﬁc HIV incidence rates for the pre-ART era and for the ART-era
rom the ASSA model for the Western Cape (ASSA, 2011).
We reanalyzed data from a survey in a semi-urban community in
ape Town (Johnstone-Robertson et al., 2011; Wood et al., 2012) toFig. S3 Wood et al. (2012) reanalysis
73% WHO  (2014b)
35% Dodd et al. (2014)
determine age-speciﬁc mixing patterns. During a 24-h period, 571
randomly selected participants were asked to keep a diary of their
indoor contacts and the time spent in each of the following indoor
locations: community buildings, crèches/schools, transport, work,
household, and other indoor locations. We  calculated the average
time of close contact of the contacting age group with each other
age group. We used this total time spent with other age groups
together with the transmission rate per time spent together to
calculate the number of new infections.
We  analyzed data from the Cape Town metropolitan electronic
TB register (ETR), which includes data on all TB cases notiﬁed in the
city from 2003 onwards to obtain estimates for TB treatment out-
comes. Case fatalities were all deaths occurring during treatment;
defaults included both treatment failures and stopped treatment.
We report the point estimate and the 95% conﬁdence intervals. The
University of Cape Town Research Ethics Committee considered
these analyses exempt from ethical review as the data used was
routinely collected, anonymized, and in aggregate.
We incorporated parameter uncertainty into the model by
sampling disease progression rates for each patient from a mul-
tivariate log-normal distribution. Table 1 shows the parameter
values and conﬁdence intervals that we used for the ﬁnal model.
The overall Mtb  transmission rate of the model was  ﬁtted to TB
notiﬁcation rates in Cape Town from 2009 (Wood et al., 2011a).
We initialized the model with 80% susceptible individuals; 20% of
the randomly selected individuals were latently infected with Mtb
at time zero, and most of them never developed active disease.
Median age at initialization was  30.4 years (interquartile range:
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4.5−50.1); 17.3% of individuals were HIV-positive. These num-
ers were the values that the model converged to after starting
rom different arbitrary values. Assuming that TB does not affect
ge-structure and HIV incidence, the age-structure and HIV preva-
ence should stay roughly the same when introducing TB into the
odel. We  modeled temporal trends in the HIV epidemic, by split-
ing time into a period before the HIV epidemic (1950−1984), a
eriod with HIV and no ART (1985–2004) and a period when ART
as available (2005 onwards). Except for the HIV-related param-
ters we used current parameters instead of trying to estimate all
arameters for each of the periods separately.
.4. Model update
We  modeled a population with a constant size of 10,000 indi-
iduals. The population was updated at monthly time-steps as
ndividuals aged and progressed through disease stages. At each
ime-step, we determined the Mtb  transmission potential by 5-
ear age group. We  counted the number of people with active TB
nd multiplied this by the proportion of smear positive TB cases
n an age-group. We  calculated age-speciﬁc TB incidence rates (in
-year age-groups) from the age-speciﬁc transmission potential,
sing the age-speciﬁc mixing patterns observed in the semi-urban
ommunity. All individuals without active TB or TB treatment were
onsidered susceptible to new TB infection. For newly infected
ndividuals, time of death and all other possible event times were
imulated again, using the disease progression model gems (Blaser
t al., 2015).
.5. Model output
The main model outcomes were age-stratiﬁed notiﬁcations of
ctive TB disease for HIV-negative and HIV-positive individuals.
e assumed that 73% of incident TB cases were notiﬁed in adults
WHO, 2014b) and 35% in children (Dodd et al., 2014). At each
ime-step, we recorded the number of individuals in each disease
tage stratiﬁed by 5-year age groups. Using these data, we  plotted
nnual TB incidence and prevalence rates to determine conver-
ence from the initial values. After convergence, we  plotted the
verage and 95% conﬁdence interval of active TB notiﬁcations by
-year age group. We  also compared demographic outputs such as
IV prevalence, ART coverage and age distribution to the observed
emographics.
.6. Sensitivity analyses
We  conducted sensitivity analyses for all parameters related to
he age-structure to investigate the main drivers of the age-pattern.
e varied age-speciﬁc mixing patterns and age-speciﬁc HIV inci-
ence rates. We  used extreme parameter values (random mixing,
nly modeling the HIV-negative population) to determine their
nﬂuence on the model output. We  also did a sensitivity analysis of
B progression rates in retreatment TB cases assuming that TB pro-
ression was the same in cases reinfected after prior treatment and
n primary cases. We  conducted an analysis assuming that latent
tb  infection did not have any protective effect on the progression
f future infections. We  also looked at model outcomes before HIV
as introduced into the population and before ART was  introduced
nto the population to determine the impact of HIV and ART on
he age structure of TB. We  conducted further sensitivity analy-
es assuming a lower case detection rate in older individuals and
ssuming that previously treated patients had a higher mortality
isk.s 14 (2016) 54–61 57
3. Results
3.1.1. Data analyses and model parameters
Of 103,304 new cases of tuberculosis notiﬁed between 2003 and
2012, 4.3% died (case fatality rate), 9.4% failed or stopped treatment
(default), and 86.3% completed treatment or were cured. Of 41,132
retreatment TB cases, 7.3% died, 19.4% failed treatment and 73.3%
completed treatment or were cured. The case fatality rate increased
with age for both new and retreatment TB. Treatment outcomes are
shown separately for each age group and HIV status in Table S2 for
primary disease and in Table S3 for retreatment TB.
Fig. S3 shows the age-speciﬁc mixing patterns that we observed
in a semi urban settlement and used in the model. We  observed
some age-assortative mixing, and a noticeable decline in overall
indoor contact time spent among older individuals. The 35–40 year
olds mixed the most, both with each other and with children aged
between 0 and 14 years.
3.2. Model ﬁt
The modeled notiﬁcation rates of active TB reproduced the
shape of the observed age pattern in TB notiﬁcation rates in 2009,
with a drop in TB notiﬁcation rates around the age of 5 years, a
subsequent peak among 20–25 year old adults and an increase in
notiﬁcation rates among 30–50 year old adults. Fig. 2 (upper panel)
shows simulated TB notiﬁcation rates by age group and the TB
notiﬁcation rates observed in the HIV-negative population of Cape
Town. Some differences were apparent. A second peak occurred at
age 45–50 years in the observed TB notiﬁcation rates. In the sim-
ulated TB notiﬁcation rates, the increase in TB notiﬁcation rates
continued. In the HIV-positive population, neither the notiﬁcation
data nor the simulations indicated that TB incidence varied by age
(Fig. 2 lower panel).
We estimated the overall Mtb  transmission rate to be 10 (6−15)
per year. The simulation converged to a stable equilibrium within
10 years after model initialization. The notiﬁcation rates converge
to 1,080 per 100,000 person-years within the ﬁrst few years. It
took about 10 years for the prevalence of active TB to converged to
2210 per 100,000 persons. Fig. S5 shows the convergence of preva-
lence and incidence after simulation start. HIV prevalence at the end
of simulation was 11.6% with an ART coverage of 62%. Compared
to estimates in the Western Cape this is a higher HIV prevalence
than 5.1% (ASSA, 2011) and consistent with ART coverage of 63%.
(Hermans et al., 2015a). The age pyramid at the end of simula-
tion was  very similar to the 2014 Cape Town age pyramid, with
the exception of a higher proportion of children aged 5−20 years
(Fig. S9).
3.3. Sensitivity analyses
Fig. 3 shows the results of the sensitivity analyses. The age-
speciﬁc TB notiﬁcation rates in HIV-negative individuals for each of
the sensitivity analyses are shown. The lines represent the median
results and the shaded areas contain 95% of simulations. In Fig. 3a
we show the base analysis for comparison. In the scenario without
protective effect (Fig. 3b), we assumed that latent infection with
a second strain of Mtb  did not provide any protective effect on
progression to active disease. In the analysis assuming no faster
progression after treatment (Fig. 3c), we assumed that TB progres-
sion after treatment was exactly the same as the progression for
the ﬁrst TB episode. In Figs. 3d−f we  show the sensitivity analyses
that made little difference: the analysis assuming no HIV incidence
and the analysis assuming random mixing. Figs. 3g and h show
the sensitivity analyses that attempt to explain the decline in TB
notiﬁcation rates in the 50 to 80 year old population.
58 N. Blaser et al. / Epidemic
Fig. 2. Age-stratiﬁed graph, including uncertainty. The upper panel shows TB
notiﬁcation rates in the HIV-negative population and the lower panel shows TB
notiﬁcation rates in the HIV-positive population. The dots and conﬁdence intervals
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tepresent the data reported in Wood et al. (2011a) and the gray lines represent one
odel run each.
The model was most sensitive to varying assumptions on the
rotective effect of previous latent Mtb  strains and to retreatment
B progression rates. The assumption of a protective effect had a
arge inﬂuence on the level of the TB notiﬁcation rates (Fig. 3b).
hen assuming that re-infection with another strain of Mtb  while
eing latently infected did not provide any protective effect on
rogression to active disease, the overall TB notiﬁcation rate was
uch higher (1628 per 100,000 person-years) than in the base anal-
sis (451 per 100,000 person-years). Assuming that retreatment
B progression rates were the same as progression rates for pri-
ary TB resulted in the TB notiﬁcation rates in adults decreasing
y 35.3%. This decrease was  more pronounced (46.6%) among indi-
iduals over 50 (Fig. 3c). The decline in TB notiﬁcation rates after
arly adulthood was not seen in the analysis without the protec-
ive effect of a previous latent Mtb  infection (Fig. 3b). The last peak
n adults was absent in the scenario without faster progression to
ctive TB in previously treated patients (Fig. 3c). HIV incidence had
ittle effect on the age-structure of TB notiﬁcation rates in the HIV-
egative population (Fig. 3d). Overall TB notiﬁcation rates increased
apidly from less than 500 notiﬁcations per 100,000 person years
o around 900 notiﬁcations per 100,000 person years when HIV
as introduced in the model (Fig. S7). They decreased slightly to
bout 700 notiﬁcations per 100,000 person years after the introduc-
ion of ART. But TB notiﬁcation rates in HIV negative individualss 14 (2016) 54–61
of all age groups remained stable throughout the three eras (Fig.
S8). When we  assumed random mixing instead of age-assortative
mixing, TB notiﬁcation was essentially unchanged (Fig. 3e). If we
assumed progression rates in children was  twice as fast as in our
base assumptions, TB notiﬁcations in children increased, but the
age pattern in adults remained the same.
To explain the lack of ﬁt in 50−80 year old adults we  performed
additional sensitivity analyses. Having a higher mortality in pre-
viously treated patients led to a decline of TB notiﬁcation rates
in older individuals, but it also resulted in a less sharp increase
in 30–50 year old adults (Fig. 3g). A lower detection rate in older
individuals seems to ﬁt the observed age pattern well (Fig. 3h).
4. Discussion
We  used a mathematical simulation model to examine the
drivers underlying the age-patterns in TB notiﬁcation rates
observed in Cape Town. We replicated the age-structure of TB noti-
ﬁcations in Cape Town up to 50 years of age in our model. We
found that the ﬁrst peak in children is likely due to high trans-
mission and rapid progression in children. The second peak is
probably explained by relatively rapid progression in early adult-
hood whereas the increase between 30 and 50 year olds was
explained by disease in previously treated patients. Our sensitiv-
ity analyses showed that age-speciﬁc TB notiﬁcation rates mostly
depended on the protective effect of previous latent infection
and the fast progression in previously treated patients. When we
assumed no protective effect of previous latent infections, the
decline in TB notiﬁcation rates around the age of 25 years disap-
peared and TB notiﬁcation rates remained high in adulthood. This
suggests that the decline after the secondary peak in TB notiﬁcation
rates is partially due to a protective effect of latent Mtb infection
on progression to active TB upon infection with a second strain.
The last increase in TB notiﬁcation rates disappeared in our sen-
sitivity analysis assuming no faster progression to TB disease in
previously treated patients, which suggests that this faster pro-
gression determines the increased rates in 45−50 year olds. The
sensitivity analyses also suggest that the age-pattern observed in
the HIV-negative population is not affected by age-speciﬁc social
mixing patterns or by HIV-associated TB. Mtb  transmission rates
also did not affect TB notiﬁcation rates as much as might have been
expected, perhaps because exposure is saturated and most of those
exposed to Mtb  never develop active TB; additional exposure may
not affect TB incidence very much.
In 50−80 year old adults, the model did not reproduce the
decline in notiﬁcation rates observed in the data. This led us to
explore additional factors as a possible explanation for the lack of
ﬁt. A higher mortality among previously treated patients improved
the ﬁt, but a reduced case detection rate in older individuals seemed
to ﬁt the observed age pattern the best. However this lower detec-
tion incorporated in the model was  chosen to ﬁt the age pattern
above 50 years. Further research is needed to further elucidate the
causes of the declining notiﬁcation rates at older ages.
Our study has several strengths. We  included detailed, time-
dependent disease progression rates observed in Cape Town. All
parameter values except for the overall transmission rate were
extraneously set and parameter uncertainty was included wher-
ever possible. We  also conducted detailed sensitivity analyses.
There are also several limitations to our model. As outlined above,
the model did not ﬁt the age-structured TB notiﬁcation rates in HIV-
negatives perfectly. Since all parameters were set exogenously, we
believe that the model ﬁt was good without over-ﬁtting the data.
The model did not ﬁt the data well for HIV-positives below the
age of 15 and above the age of 40, probably because we  did not
include mother-to-child transmission of HIV and because of the
uncertainty in the denominators in the data. The age distribution
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Fig. 3. Sensitivity analyses. The age-speciﬁc TB notiﬁcation rates in HIV-negative individuals for each of the sensitivity analyses are shown. The lines represent the median
results  and the shaded areas contain 95% of simulations. Panel a shows the base analysis, Panel b shows the analysis without a protective effect of previous TB strains and
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e  assumed random mixing. Panel f shows the analysis where we assumed childre
igher  mortality in previously treated patients and panel h shows the simulation re
-axis  differ.
f the simulated population differed slightly from the observed data
n Cape Town in children and adolescents (Fig. S9). We  also assumed
hat HIV incidence was independent of TB status (susceptible, latent
nfection, disease, recovered), even though van Schalkwyk et al.
Van Schalkwyk et al., 2014) suggest otherwise. We  used average
IV incidence rates for the pre-ART and ART era, which may  have
ffected TB notiﬁcation rates in the HIV-positive population. We
id not use historical parameters to model the pre-HIV era TB epi-
emic. We  feel that that would have added a lot of uncertainty
bout the model parameters to our study while adding little infor-
ation. The most important changes in TB incidence during the
ast 30 years were due to HIV and the introduction of ART. Since
ur focus was the age structure in an HIV-negative population,analysis in an entirely HIV-negative population. Panel e shows the analysis where
gressed to active TB twice as fast. Panel g shows the analysis where we assumed a
ssuming lower case detection rate in older individuals. Note that the scales on the
which remained similar during the last 10 years and was insen-
sitive to HIV, we do not believe that this is a major limitation.
Nevertheless, the rates in the pre-HIV and HIV eras we estimated
are very similar to historical rates from this setting (Hermans et al.,
2015b). A further limitation is that we did not include CD4 cell count
of HIV-positive patients in the model. This could have impacted
the estimates in the HIV-positive population. Since the focus of
this study was on HIV-negative individuals and the HIV infected
population did not substantially inﬂuence the age structure of TB
in HIV-negative people, we  think adding CD4 would have added
unnecessary complexity to the model. We  assumed that all patients
who cleared active TB naturally or after being treated successfully
became susceptible and uninfected. Some accuracy may have been
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ost when we divided the model into discrete time steps. Our age-
ixing matrix may  have underestimated the contacts of elderly
eople, because we only used indoor contacts in schools, work-
laces, and transport. But this is unlikely to signiﬁcantly affect our
esults, since the sensitivity analysis showed that random mixing
ed to the same age-pattern.
In contrast to the many HIV models in which age-speciﬁc preva-
ence and incidence were used extensively to validate models
Bershteyn et al., 2013; Cambiano et al., 2013), we believe ours is
he ﬁrst mathematical model of Mtb  transmission to focus on age-
peciﬁc TB notiﬁcations in sub-Saharan Africa. Although a number
f previous TB models were stratiﬁed by age (Dye et al., 1998;
chulzer et al., 1994; Stover et al., 2010), they did not compare
odeled age-speciﬁc TB notiﬁcations to available data. For most
f them, age-stratiﬁcation was mainly intended to capture age-
peciﬁc HIV prevalence. Dodd et al. (Dodd et al., 2014) used a
tatic population model and a household model to estimate the
ncidence of pediatric TB based on adult notiﬁcation rates. Vyn-
ycky and Fine (Vynnycky and Fine, 1997) explicitly incorporated
ge-structure in a TB transmission model, and found that age and
einfections were major factors in the spread of TB in England and
ales, where HIV is not a primary driver of TB. Our results extend
heir ﬁndings to settings with endemic HIV. Our estimate of the
verall Mtb  transmission rate of 10.0 per year was similar to the
stimate of Vynnycky and Fine (Vynnycky and Fine, 1999) for 1950
ngland. It is also consistent with Bacaer et al. (Bacaer et al., 2008)
ho estimated a Mtb  transmission rate of 11.4 per year in Cape
own.
Our results have important implications for TB prevention and
reatment programs. Our model results suggest that TB interven-
ions, such as DOTS, TB screening, IPT, and ART in HIV-infected
B patients should take age into account. IPT and case ﬁnding
ay  be particularly important in young adults considering the
apid progression rates in early adulthood. Similarly, new pre-
ention programs could target case ﬁnding at previously treated
atients aged 40–50 years. Focusing interventions on the most at-
isk age groups may  increase their effectiveness (Lawn et al., 2006).
ore research is needed to determine the implications of the age-
ependent progression rates on TB control.
In conclusion, by including age strata, we were able to replicate
he age-structure of TB incidence in Cape Town up to 50 years of age.
ore research is needed to determine the causes for declining TB
otiﬁcation rates with increasing age. The protective effect of a ﬁrst
atent infection on subsequent infections and the faster progression
o disease among previously treated patients are the key factors in
xplaining the age-structure of TB incidence in Cape Town.
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